共 5 条
[2]
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy:: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2007, 18 (05)
:1540-1546
[3]
Renoprotection of Optimal Antiproteinuric Doses (ROAD) study: A Randomized controlled study of benazepril and losartan in chronic renal insufficiency
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2007, 18 (06)
:1889-1898